Biological Adhesive Development Receives Six Figure Backing

Posted on 6/12/2019 7:55:00 AM By ASC

A young biotech company formed in 2017 by scientists from Bristol University in the UK, Zentraxa, has received an investment of ₤500,000 to assist it in funding its development of biological adhesives for use in areas such as wound dressings and healthcare in general. 

According to Zentraxa, which focuses on bio-production of peptides for application in various materials, the adhesives will be manufactured using its own bio-materials and its own manufacturing process, Zentide, which is based on similar processes to those found in the natural world. 

The company intends to use the investment, part of which was from the Bristol Private Equity Fund, to take the development of the adhesives up a notch from its current feasibility or laboratory stage to the point where it is ready for pilot testing.


comments powered by Disqus